Tamoxifen breeds resistance in breast cancer
The presence of lower-than-normal amounts of the protein TGFBR2 was associated with breast cancer resistance to treatment with the antiestrogen tamoxifen, according to a study published in Cancer Research. “Our studies established the role of the cell signaling protein TGFBR2 …